Panion’s market research initiative
Panion Animal Health is a veterinary drug company; the company’s business idea is to develop medicines and treatment methods that create a better life for animals. The first asset in development is a gene therapy to treat drug-refractory epilepsy in dogs. In addition, Panion aims to in-license other development projects. Panion Animal Health is currently undertaking a major market research initiative in order to evaluate multiple in-licensing opportunities. We are working with a New York-based market research firm which has a database of over 50,000 US-based veterinarians. This database